Biohaven Ltd. (BHVN)
12.92
-0.28
(-2.08%)
USD |
NYSE |
Sep 25, 11:19
Biohaven Price : 12.92 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | 13.43 | 13.63 | 12.76 | 13.19 | 3.026M |
| Sep 23, 2026 | 14.84 | 14.84 | 13.51 | 13.67 | 2.743M |
| Sep 22, 2026 | 14.42 | 14.97 | 14.22 | 14.85 | 2.433M |
| Sep 21, 2026 | 13.90 | 14.49 | 13.56 | 14.22 | 3.294M |
| Sep 18, 2026 | 14.07 | 14.37 | 13.46 | 13.62 | 6.432M |
| Sep 17, 2026 | 12.18 | 14.32 | 12.05 | 13.89 | 5.834M |
| Sep 16, 2026 | 12.34 | 12.44 | 11.93 | 12.02 | 2.253M |
| Sep 15, 2026 | 12.57 | 12.67 | 11.96 | 12.34 | 3.083M |
| Sep 14, 2026 | 12.52 | 12.87 | 12.52 | 12.64 | 1.649M |
| Sep 11, 2026 | 13.03 | 13.37 | 12.58 | 12.71 | 2.863M |
| Sep 10, 2026 | 13.52 | 13.84 | 12.44 | 12.79 | 8.322M |
| Sep 09, 2026 | 14.62 | 15.46 | 14.42 | 15.00 | 2.817M |
| Sep 08, 2026 | 14.91 | 15.80 | 14.33 | 14.72 | 3.307M |
| Sep 04, 2026 | 15.52 | 15.80 | 15.21 | 15.69 | 1.901M |
| Sep 03, 2026 | 15.89 | 16.29 | 15.46 | 15.86 | 2.259M |
| Sep 02, 2026 | 15.97 | 16.66 | 14.98 | 15.69 | 2.679M |
| Sep 01, 2026 | 15.39 | 16.04 | 14.88 | 15.74 | 2.480M |
| Aug 31, 2026 | 15.46 | 15.79 | 15.18 | 15.27 | 2.927M |
| Aug 28, 2026 | 15.88 | 16.34 | 14.94 | 15.41 | 2.888M |
| Aug 27, 2026 | 16.95 | 17.05 | 15.50 | 16.12 | 5.427M |
| Aug 26, 2026 | 14.24 | 18.24 | 13.00 | 16.95 | 15.77M |
| Aug 25, 2026 | 13.96 | 14.86 | 13.92 | 14.38 | 3.442M |
| Aug 24, 2026 | 13.95 | 14.00 | 13.56 | 13.68 | 1.356M |
| Aug 21, 2026 | 13.60 | 14.33 | 13.53 | 13.85 | 2.086M |
| Aug 20, 2026 | 13.96 | 14.52 | 13.26 | 13.50 | 4.017M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0103 |
| Brainstorm Cell Therapeutics, Inc. | 0.9498 |
| Summit Therapeutics, Inc. | 16.25 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 3.285 |
Price Related Metrics
| Price to Book Value | 159.58 |
| Earnings Yield | -35.97% |
| Market Cap | 1.950B |